Product Images Rosuvastatin Calcium
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 8 images provide visual information about the product associated with Rosuvastatin Calcium NDC 60290-043 by Umedica Laboratories Private Limited, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
image description - rosuvastatin tablets 10mg 30s bottle label
Each tablet contains Rosuvastatin calcium equivalent to 10mg of Rosuvastatin. This medication is to be kept out of reach of children and stored at controlled room temperature between 20°C to 25°C (68°F to 77°F). It is important to protect the medication from moisture. The tablets are manufactured by Umedica Laboratories Ltd. in Vapi, Gujarat, India. The NDC number is 60290-044-01. The prescription information should be accompanied by the patient information sheet. The manufacturer's website can be visited at https://umedicalabs.com/ or they can be contacted at 18502862511. The lot number and expiration date are not available.*
image description - rosuvastatin tablets 20mg 30s bottle label
image description - rosuvastatin tablets 40mg 30s bottle label
This text appears to be the description of a medication called Rosuvastatin. It states that each tablet contains 40mg of Rosuvastatin calcium. The recommended dosage and storage instructions are also provided. It mentions that the medication should be kept out of the reach of children and stored at a controlled room temperature. The text also includes information about the manufacturer and a contact number for patient information. However, the text does not include clear information on the purpose or indications of this medication.*
image description - rosuvastatin tablets 5mg 30s bottle label
figure_1_time_jupiter - rosuvastatin tablets figure 1
This text appears to be a statistical analysis of two different groups (HR 0.56, 95% Cl 0.46-0.69) with a significant difference in outcomes (P<0.001). The cumulative incidence of the groups is represented as a percentage over time. Unfortunately, the rest of the text seems to be incoherent and does not provide any further information.*
figure_2-major_jupiter - rosuvastatin tablets figure 2
figure_3_percent_dyslipidemia - rosuvastatin tablets figure 3
structural_formula - rosuvastatin tablets structure
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.